BioSpace News Archive

Deals

Akari Therapeutics Enters into a Securities Purchase Agreement for up to $20 Million with Aspire Capital Fund, LLC

Akari Therapeutics, Plc today announces that it has entered into a Securities Purchase Agreement (the “Agreement”) of up to $20 million with Aspire Capital Fund, LLC

September 30, 2018
·
6 min read
The International Society for Augmentative and Alternative Communication to Launch International AAC Awareness Month 2018

The October Awareness Month to promote communication technology for people with complex communication needs

September 30, 2018
·
3 min read
Policy

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Alnylam Pharmaceuticals, Inc. (ALNY) and Encourages ALNY Investors to Contact the Firm

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Alnylam Pharmaceuticals, Inc. (ALNY) securities between February 15, 2018 through September 12, 2018 (the “Class Period”).

September 30, 2018
·
1 min read
Business

NetScientific Interim Results for the six months ended 30 June 2018

NetScientific plc today announces its interim results for the six months ended 30 June 2018.

September 30, 2018
·
5 min read
How Malaria parasites could help beat symptoms of Chikungunya

Singapore scientists’ discovery could hold the key to novel treatments for the symptoms of mosquito-borne diseases

September 30, 2018
·
4 min read
Major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs

Clyde Biosciences announced today that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro cardiac safety evaluation of new drugs.

September 30, 2018
·
3 min read
Microbix to Present at Muskoka Capital Conference

Conference Introduces Growth Companies to Investor September 28-30, 2018

September 30, 2018
·
3 min read
Business

Johnson & Johnson Announces New Collaboration to Advance Novel Vaccine for MERS

New collaboration with Coalition for Epidemic Preparedness Innovations (CEPI) and The Jenner Institute is latest example of Johnson & Johnson’s ongoing commitment to global pandemic preparedness efforts

September 30, 2018
·
8 min read
Business

Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET® (Avatrombopag)

Salix Sales Force to Promote First FDA-Approved Drug for Thrombocytopenia in Chronic Liver Disease Patients Scheduled to Undergo a Procedure

September 30, 2018
·
12 min read
Pharm Country

TARA Biosystems Announces Launch of Cardiotype.Fo, Best-in-Class In Vitro Assay for Assessment of Cardiac Contractility

TARA Biosystems Inc. announced today the launch of Cardiotype.Fo, the best-in-class in vitro system for assessment of cardiac contractility.

September 30, 2018
·
2 min read